Date: 2017-07-27
Type of information: Opening of new premises
Compound: expansion in BioMarin Shanbally
Company: Biomarin Pharmaceutical (USA - CA)
Therapeutic area: Rare diseases - Genetic diseases
Type agreement: opening of new premises
Action mechanism:
Disease:
Details:
- • On July 27, 2017, Simon Coveney TD, Minister for Foreign Affairs and Trade, officially opened a new expansion at BioMarin Pharmaceutical Inc. in Shanbally, Co Cork. BioMarin has recently extended its site footprint to 20 acres. Since opening its doors in 2011, the company has grown to 365 employees in Cork, with an additional 67 people based in Dublin and 2,400 employees globally.
- This expansion project began two years ago to cater for continued growth at the site and includes an expanded warehouse, new administration and utilities offices, a canteen and conference facilities. The overall project will allow the company to maximise the flexibility of the site with the expansion of the operational manufacturing capacity. The site will also see the installation of a Waste Water Treatment Plant later this year, while three new lab expansions are to be completed by Q3 2018.
- BioMarin Shanbally was certified by the Health Products Regulatory Authority (HPRA), on behalf of the European Medicines Agency (EMA), in Q1 2017. The Shanbally site was subsequently licensed for commercial supply by the US FDA in May this year for a range of activities including bulk production, Quality Control testing, Quality Assurance release, final product secondary packaging (labeling and packaging) and distribution.
Financial terms:
Latest news:
Is general: Yes
